StonvexLoading…
StonvexStonvexStonvexCore line items from XWIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.72M | $9.69M | $11.09M | $12.74M |
Operating Income | $-1.93M | $-5.36M | $-6.42M | $-16.22M |
Net Income | $-3.42M | $-5.56M | $-7.72M | $-17.10M |
EPS (Diluted) | $-0.17 | $-1.48 | $-4.96 | $-12.34 |
Total Assets | $35.55M | $9.92M | $6.24M | $11.53M |
Total Liabilities | $7.59M | $6.79M | $5.74M | $4.92M |
Cash & Equivalents | $6.71M | $161.90K | $369.14K | $1.37M |
Free Cash Flow OCF − CapEx | Not available | $-1.41M | Not available | $-5.38M |
Shares Outstanding | 41.89M | 7.30M | 1.92M | 1.43M |